Ingen pharmaceuticals - Company finances
|
EUR
|
2023
From: 2023-03-21
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | - | - | - |
| Profit before tax | - | - | -8,259 |
| Net profit | -602 | 0 | -8,259 |
| Equity | 7,398 | 7,398 | -861 |
| Liabilities | 0 | 0 | 0 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 7,398 | 7,398 | 7,930 |
| Total assets | 7,398 | 7,398 | 7,930 |
|
Taxes paid
|
|||
| STI taxes | - | - | 1,732 |
|
Financial indicators
|
|||
| Revenue change y/y | - | - | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -8.1% | 0.0% | -104.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -8.1% | 0.0% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ingen pharmaceuticals - Social security debts
The amount of overdue SODRA debt for the company Ingen pharmaceuticals as of the last working day is: 0 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-15 | 0.15 |
| 2026-08-26 | 2026-09-02 | 0.15 |
| 2026-08-23 | 2026-08-23 | 0.15 |
| 2026-08-19 | 2026-08-19 | 0.15 |
| 2026-08-16 | 2026-08-17 | 0.15 |
| 2026-07-19 | 2026-08-14 | 0.15 |
| 2026-06-11 | 2026-07-17 | 0.15 |
| 2026-05-17 | 2026-06-08 | 0.15 |
| 2026-05-03 | 2026-05-14 | 0.15 |
| 2026-04-20 | 2026-04-29 | 0.15 |
| 2026-03-29 | 2026-04-15 | 0.15 |
| 2026-03-15 | 2026-03-27 | 0.15 |
| 2026-01-21 | 2026-03-11 | 0.15 |
| 2025-11-18 | 2025-11-19 | 295.46 |
| 2025-07-22 | 2025-07-22 | 221.60 |
Ingen pharmaceuticals - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-11-14 | 2025-11-20 | 0.35 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.